-
1تقرير
المساهمون: Xiaoxiang Chen, Academic secretary of gynecological oncology Committee of Jiangsu anti cancer association
المصدر: A Prospective, Single-arm, Single-center, Exploratory Phase II Study to Evaluate the Efficacy and Safety of Anlotinib Combined With Dose-reduced Olaparib in Patients With Platinum-Sensitive Recurrent Ovarian Cancer
الوصول الحر: https://clinicaltrials.gov/ct2/show/NCT04566952Test
-
2تقرير
المساهمون: Xiaoxiang Chen, Academic secretary of gynecological oncology Committee of Jiangsu anti cancer association
المصدر: A Single-arm, Prospective, Open-label, Phase II Study to Evaluate the Efficacy and Safety of Niraparib Combined With Bevacizumab in Platinum Refractory/Resistant Recurrent Ovarian, Fallopian Tube or Peritoneal Cancer
الوصول الحر: https://clinicaltrials.gov/ct2/show/NCT04556071Test
